Upregulated FATP2 enhances PMN-MDSC-mediated CD8+ T cell suppression through increased glycerol trioleate uptake and prostaglandin E2 (PGE2) synthesis, thereby promoting tumor progression (Veglia et al., 2019). Here, CD8A is linked to neoplasm.